Search Results
You are looking at 1 - 2 of 2 items for
- Author: Tian-Hong Zhu x
- Refine by access: All content x
Search for other papers by Tian-Hong Zhu in
Google Scholar
PubMed
Search for other papers by Shao-Jie Ding in
Google Scholar
PubMed
Search for other papers by Tian-Tian Li in
Google Scholar
PubMed
Search for other papers by Li-Bo Zhu in
Google Scholar
PubMed
Search for other papers by Xiu-Feng Huang in
Google Scholar
PubMed
Search for other papers by Xin-Mei Zhang in
Google Scholar
PubMed
Endometriosis is an estrogen-dependent disease. Previous research has shown that abnormal enzymes associated with estrogen (E2) metabolism and an increased number of mast cells (MCs) in endometriomas are implicated in the pathogenesis of endometriosis. However, it remains unclear how MCs mediate the role of E2 in endometriosis. Accordingly, we investigated whether E2 was associated with the number of MCs, and the rate of degranulation, in local ovarian endometriomas, as well as the role of E2 on MCs during the pathogenesis of endometriosis. Using enzyme-linked immunosorbent assay and immunohistochemistry, we found that concentrations of E2, and the number and activity of MCs, were significantly higher in ovarian endometriomas than in controls, and that these parameters were correlated with the severity of endometriosis-associated dysmenorrhea. By measuring the release of hexosaminidase, we found that the rate of RBL2H3 cell degranulation increased after E2 treatment. Furthermore, activation of RBL2H3 cells by E2 was found to trigger the release of biologically active nerve growth factor, which promotes neurite outgrowth in PC12 cells and also sensitizes dorsal root ganglion cells via upregulation of Nav1.8 and transient receptor potential cation channel (subfamily V member 1) expression levels. When treated with E2, endometriotic cells could promote RBL2H3 cell recruitment by upregulating expression levels of stem cell factor, transforming growth factor-β and monocyte chemoattractant protein-1; these observations were not evident with control endometrial cells. Thus, elevated E2 concentrations may be a key factor for degranulation and recruitment of MCs in ovarian endometriomas, which play a key role in endometriosis-associated dysmenorrhea.
Key Laboratory of Animal Genetics and Breeding of the Ministry of Agriculture, College of Animal Sciences and Technology, College of Veterinary Medicine, Department of Obstetrics and Gynecology, College of Animal Sciences and Technology, China Agricultural University, Beijing 100094, People's Republic of China
Search for other papers by Wen-Min Cheng in
Google Scholar
PubMed
Search for other papers by Lei An in
Google Scholar
PubMed
Search for other papers by Zhong-Hong Wu in
Google Scholar
PubMed
Search for other papers by Yu-Bo Zhu in
Google Scholar
PubMed
Search for other papers by Jing-Hao Liu in
Google Scholar
PubMed
Search for other papers by Hong-Mei Gao in
Google Scholar
PubMed
Search for other papers by Xi-He Li in
Google Scholar
PubMed
Search for other papers by Shi-Jun Zheng in
Google Scholar
PubMed
Search for other papers by Dong-Bao Chen in
Google Scholar
PubMed
Search for other papers by Jian-Hui Tian in
Google Scholar
PubMed
We recently reported that electrical activation followed by secondary chemical activation greatly enhanced the developmental competence of in vitro matured porcine oocytes fertilized by intracytoplasmic sperm injection (ICSI). We hypothesized that sperm treatment with disulfide bond reducing agents will enhance the development competence of porcine embryos produced by this ICSI procedure. We examined the effects of glutathione (GSH), dithiothreitol (DTT), GSH or DTT in combination with heparin on sperm DNA structure, paternal chromosomal integrity, pronuclear formation, and developmental competence of in vitro matured porcine oocytes after ICSI. Acridine orange staining and flow cytometry based sperm chromatin structure assay were used to determine sperm DNA integrity by calculating the cells outside the main population (COMP αT). No differences were observed in COMP αT values among GSH-treated and control groups. COMP αT values in GSH-treated groups were significantly lower than that in DTT-treated groups. Following ICSI, GSH treatments did not significantly alter paternal chromosomal integrity. Paternal chromosomal integrity in sperm treated with DTT plus or minus heparin was also the lowest among all groups. GSH-treated sperm yielded the highest rates of normal fertilization and blastocyst formation, which were significantly higher than that of control and DTT-treated groups. The majority of blastocysts derived from control and GSH-treated spermatozoa were diploid, whereas blastocysts derived from DTT-treated spermatozoa were haploid. In conclusion, sperm treatment with GSH enhanced the developmental capacity of porcine embryos produced by our optimized ICSI procedure.